Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Treatment Outcome for Symptomatic Patients with Clonal Cytopenia of Undetermined Significance: A Single-Institution Retrospective Study

Zhuoer Xie, MD, Ahmad Nanaa, Antoine Saliba, MD, Rong He, MD, Phuong L. Nguyen, MD, Dragan Jevremovic, MD PhD, Patricia Greipp, DO, Mohamed Salama, MD, Naseema Gangat, MBBS, Hassan B. Alkhateeb, MD, Ayalew Tefferi, MD, Mark Litzow, MD, Mrinal M. Patnaik, MDMBBS, Mithun Vinod Shah, MD PhD, Aref Al-Kali, MD

Blood (2020) 136 (Supplement 1): 44.

https://doi.org/10.1182/blood-2020-137527

Published: 2020

Journal Articles

Spectrum of Hematological Malignancies in 130 Patients with Germline Predisposition Syndromes - Mayo Clinic Germline Predisposition Study

Blood (2020) 136 (Supplement 1): 34–35.

https://doi.org/10.1182/blood-2020-139050

Published: 2020

Journal Articles

Predictors of Survival and Time to Progression to Myeloid Neoplasm in Patients with Clonal Cytopenias

Ahmad Nanaa, Rama Nana, Zhuoer Xie, MD, Dragan Jevremovic, MD PhD, Phuong L. Nguyen, MD, Cynthia Hengel, Susan M. Geyer, PhD, Rong He, MD, David S. Viswanatha, MD, Michael M. Timm, Mohamed E Salama, MD, Min Shi, MDPhD, Patricia Greipp, DO, Hassan B. Alkhateeb, MD, William J Hogan, MB, BCh, Mark Litzow, MD, Mrinal M. Patnaik, MDMBBS, Mithun Vinod Shah, MD PhD, Aref Al-Kali, MD

Blood (2020) 136 (Supplement 1): 26–27.

https://doi.org/10.1182/blood-2020-142181

Published: 2020

Journal Articles

Predicted Leukocyte Telomere Length and Risk of Myeloid Neoplasms

Jenny Poynter, PhD, Spencer Kelley, Marina Marcato, Erica Langer, Anthony J Hooten, Mary Rachel Stimson, Michelle A. Roesler, BS, Phuong L. Nguyen, MD, Adina Cioc, MD, Erica D. Warlick, MD, Nathan Pankratz

Blood (2019) 134 (Supplement_1): 1335.

https://doi.org/10.1182/blood-2019-131224

Published: 2019

Journal Articles

History of Autoimmune Disease Is Associated with Increased Risk for Myelodysplastic Syndromes

Michelle A. Roesler, BS, Amy Linabery, PhD MS, Michaela Richardson, MPH, Adina Cioc, MD, Betsy A Hirsch, PhD, Phuong L. Nguyen, MD, Erica D. Warlick, MD, Jenny Poynter, PhD

Blood (2019) 134 (Supplement_1): 3014.

https://doi.org/10.1182/blood-2019-130940

Published: 2019

Journal Articles

Comparison of α LEPRA and α LELY Co-Inheritance with a SPTA1 Whole Gene Deletion, a Family Study

Molly S. Hein, Lea Coon, MS, LCGC, Tavanna R. Porter, MS, LCGC, Rong He, MD, Michelle E. Savedra, MT(ASCP), Laura J. Train, BS, Linnea M. Baudhuin, PhD, Andre M. Oliveira, MD PhD, Phuong L. Nguyen, MD, James D. Hoyer, MD, Aruna Rangan, MD, Jennifer L. Oliveira, MD

Blood (2019) 134 (Supplement_1): 2228.

https://doi.org/10.1182/blood-2019-125691

Published: 2019

Journal Articles

Effects of Voxelotor (GBT440) Therapy on Laboratory Testing of Sickle Cell Patients

Michelle E. Savedra, MT(ASCP), Jessica L. Szuberski, MLS ASCP, Tavanna R. Porter, MS, LCGC, Molly S. Hein, Phuong L. Nguyen, MD, Min Shi, MD PhD, Aruna Rangan, MD, James D. Hoyer, MD, Jennifer L. Oliveira, MD

Blood (2019) 134 (Supplement_1): 1011.

https://doi.org/10.1182/blood-2019-131125

Published: 2019

Journal Articles

Correlation of Flow Cytometric Aberrations with Cytogenetic, Molecular Genetic, and Morphology in Patients with Unexplained Cytopenias

Haya Azouz, Jessica Ternus, Phuong L. Nguyen, MD, Dragan Jevremovic, MD PhD, Mrinal M Patnaik, MDMBBS, Michael M. Timm, Min Shi, MD PhD, Rong He, MD, David S. Viswanatha, Mithun Vinod Shah, MD PhD, Hassan B. Alkhateeb, MD, Naseema Gangat, MBBS, Kebede H. Begna, MD, William J Hogan, MB, BCh, Mark Litzow, MD, Cindy Hengel, Aref Al-Kali, MD

Blood (2019) 134 (Supplement_1): 5406.

https://doi.org/10.1182/blood-2019-125114

Published: 2019

Journal Articles

Discrepancy of Blast Percentage between the Bone Marrow Aspirate and Flow Cytometry and Its Impact on Survival Outcomes in Patients with Myelodysplastic Syndromes Excess Blast (MDS-EB)

Meera Yogarajah, MD, Phuong L. Nguyen, MD, Rong He, MD, Hassan B. Alkhateeb, MD, Mithun Vinod Shah, MD PhD, Mrinal M Patnaik, MDMBBS, Kebede H. Begna, MD, Michelle A Elliott, MD, Naseema Gangat, MBBS, William J Hogan, MB, BCh, Ayalew Tefferi, MD, Mark Litzow, MD, Aref Al-Kali, MD

Blood (2019) 134 (Supplement_1): 5441.

https://doi.org/10.1182/blood-2019-125439

Published: 2019

Journal Articles

Frequency of Acquired Genetic Mutations and Their Prognostic Impact on Patients with Incidental Finding of Isolated 20q- in Bone Marrow without Morphologic Evidence of a Myeloid Neoplasm

Aishwarya Ravindran, MBBS, Rong He, MD, Majd D. Jawad, MD, Rhett P. Ketterling, Dong Chen, MD PhD, Jennifer L. Oliveira, MD, Phuong L. Nguyen, MD, David S. Viswanatha, MD, Kaaren K. Reichard, MD, James D. Hoyer, MD, Ronald S. Go, MD, Min Shi, MD PhD

Blood (2018) 132 (Supplement 1): 4382.

https://doi.org/10.1182/blood-2018-99-117821

Published: 2018

Journal Articles

Factors Predicting Early Mortality in Newly Diagnosed Myelodysplastic Syndrome (MDS): A Population Based Study

Annie M. Jacobsen, MD, Jenny Poynter, PhD, Michaela Richardson, MPH, Phuong L. Nguyen, MD, Betsy A Hirsch, PhD, Adina Cioc, MD, Michelle A. Roesler, BS, Erica D. Warlick, MD

Blood (2018) 132 (Supplement 1): 4369.

https://doi.org/10.1182/blood-2018-99-112319

Published: 2018

Journal Articles

Marrow Blast Percentage Impact on High-Grade Myelodysplastic Syndrome By the Revised International Prognostic Scoring System

Omar Alkharabsheh, MBBS, Mrinal M. Patnaik, MD MBBS, Naseema Gangat, MBBS, Kebede H. Begna, MD, Hassan B. Alkhateeb, MD, Mithun Vinod Shah, MD PhD, William J. Hogan, MBBCh, Rong He, MD, Patricia Greipp, DO, Phuong L. Nguyen, MD, Mark R. Litzow, MD, Aref Al-Kali, MD

Blood (2018) 132 (Supplement 1): 5510.

https://doi.org/10.1182/blood-2018-99-113943

Published: 2018

Journal Articles

Outcome of Patients Younger Than 50 Years Old Diagnosed with Myelodysplastic Syndromes (MDS): Single Institution Experience

Aref Al-Kali, MD, Rong He, MD, Mrinal M Patnaik, MBBS, David S Viswanatha, MD, Patricia T. Greipp, DO, Darci Zblewski, CNP, Michelle Elliott, MD, Naseema Gangat, MBBS, Ayalew Tefferi, MD, Mark R. Litzow, MD, Phuong L. Nguyen, MD

Blood (2016) 128 (22): 5541.

https://doi.org/10.1182/blood.V128.22.5541.5541

Published: 2016

Journal Articles

Clinical Spectrum of Germline Mutations with Predisposition to Myeloid Neoplasms- 2016 World Health Organization Classification Update

Thanh Ho, MD, Juliana Perez Botero, MD, William J Hogan, MBChB, Saad S Kenderian, MD, Naseema Gangat, MBBS, Ayalew Tefferi, MD, Roshini S Abraham, PhD, Phuong L. Nguyen, MD, Jennifer L Oliveira, MD, Rong He, MD, Dong Chen, MD PhD, David Viswanatha, MD, Vilmarie Rodriguez, MD, Shakila Khan, MD, Mrinal M Patnaik, MBBS

Blood (2016) 128 (22): 300.

https://doi.org/10.1182/blood.V128.22.300.300

Published: 2016

Journal Articles

Association Between Mitochondrial DNA Haplogroup and Myelodysplastic Syndromes

Jenny N Poynter, PhD, Michaela Richardson, Erica Langer, Anthony Hooten, Michelle A. Roesler, BS, Betsy A. Hirsch, PhD, Phuong L. Nguyen, MD, Adina Cioc, MD, Erica Warlick, MD, Julie A Ross, PhD

Blood (2015) 126 (23): 2885.

https://doi.org/10.1182/blood.V126.23.2885.2885

Published: 2015

Journal Articles

Family History Of Hematologic Malignancies and Disorders In a Population Based Study Of Myelodysplastic Syndromes (MDS)

Angela R. Smith, MD, MS, Erica D. Warlick, MD, Rachel K. Fonstad, M.S., Michelle A. Roesler, Jenny N. Poynter, PhD, Betsy Hirsch, PhD, Phuong L. Nguyen, MD, Adina Cioc, MD, Julie A Ross, PhD

Blood (2013) 122 (21): 1541.

https://doi.org/10.1182/blood.V122.21.1541.1541

Published: 2013

Journal Articles

Differences In Community and Academic Practice Patterns For Newly Diagnosed Myelodysplastic Syndromes (MDS) Patients In Minnesota: A Population Based Study

Daniel Pease, MD, Julie A Ross, PhD, Phuong L. Nguyen, MD, Betsy Hirsch, PhD, Adina Cioc, MD, Angela R. Smith, MD, MS, Michelle A. Roesler, Rachel K. Fonstad, M.S., Erica D. Warlick, MD

Blood (2013) 122 (21): 2798.

https://doi.org/10.1182/blood.V122.21.2798.2798

Published: 2013

Journal Articles

Discordant World Health Organization (WHO) Classifications In a Population-Based Study Of Adult Myelodysplastic Syndromes (MDS)

Erica D. Warlick, MD, Phuong L. Nguyen, MD, Rachel K. Fonstad, M.S., Adina Cioc, MD, Betsy Hirsch, PhD, Jeffrey S. Miller, MD, Daniel J. Weisdorf, MD, Michelle A. Roesler, Julie A Ross, PhD

Blood (2013) 122 (21): 1546.

https://doi.org/10.1182/blood.V122.21.1546.1546

Published: 2013

Journal Articles

Comparison of IPSS and IPSS-R Scoring in a Population Based Myelodysplastic Syndromes (MDS) Study

Erica D. Warlick, MD, Betsy A. Hirsch, PhD, Phuong L. Nguyen, MD, Adina Cioc, Michelle A. Roesler, Rachel Fonstad, M.S., Jeffrey S. Miller, MD, Daniel J. Weisdorf, MD, Julie A. Ross, PhD

Blood (2012) 120 (21): 3841.

https://doi.org/10.1182/blood.V120.21.3841.3841

Published: 2012

Journal Articles

Initial Clinical Findings From a Population-Based Study of Adult Myelodysplastic Syndrome: Discordance Between World Health Organization (WHO) Classifications

Erica D Warlick, MD, Phuong L. Nguyen, MD, Adina Cioc, Betsy A. Hirsch, PhD, Jeffrey S. Miller, MD, Daniel J. Weisdorf, MD, Michelle A. Roesler, Jessica Musselman, Julie A. Ross, PhD

Blood (2011) 118 (21): 1733.

https://doi.org/10.1182/blood.V118.21.1733.1733

Published: 2011

NARROW

Treatment Outcome for Symptomatic Patients with Clonal Cytopenia of Undetermined Significance: A Single-Institution Retrospective Study

Spectrum of Hematological Malignancies in 130 Patients with Germline Predisposition Syndromes - Mayo Clinic Germline Predisposition Study

Predictors of Survival and Time to Progression to Myeloid Neoplasm in Patients with Clonal Cytopenias

Predicted Leukocyte Telomere Length and Risk of Myeloid Neoplasms

History of Autoimmune Disease Is Associated with Increased Risk for Myelodysplastic Syndromes

Comparison of α LEPRA and α LELY Co-Inheritance with a SPTA1 Whole Gene Deletion, a Family Study

Effects of Voxelotor (GBT440) Therapy on Laboratory Testing of Sickle Cell Patients

Correlation of Flow Cytometric Aberrations with Cytogenetic, Molecular Genetic, and Morphology in Patients with Unexplained Cytopenias

Discrepancy of Blast Percentage between the Bone Marrow Aspirate and Flow Cytometry and Its Impact on Survival Outcomes in Patients with Myelodysplastic Syndromes Excess Blast (MDS-EB)

Frequency of Acquired Genetic Mutations and Their Prognostic Impact on Patients with Incidental Finding of Isolated 20q- in Bone Marrow without Morphologic Evidence of a Myeloid Neoplasm

Factors Predicting Early Mortality in Newly Diagnosed Myelodysplastic Syndrome (MDS): A Population Based Study

Marrow Blast Percentage Impact on High-Grade Myelodysplastic Syndrome By the Revised International Prognostic Scoring System

Outcome of Patients Younger Than 50 Years Old Diagnosed with Myelodysplastic Syndromes (MDS): Single Institution Experience

Clinical Spectrum of Germline Mutations with Predisposition to Myeloid Neoplasms- 2016 World Health Organization Classification Update

Association Between Mitochondrial DNA Haplogroup and Myelodysplastic Syndromes

Family History Of Hematologic Malignancies and Disorders In a Population Based Study Of Myelodysplastic Syndromes (MDS)

Differences In Community and Academic Practice Patterns For Newly Diagnosed Myelodysplastic Syndromes (MDS) Patients In Minnesota: A Population Based Study

Discordant World Health Organization (WHO) Classifications In a Population-Based Study Of Adult Myelodysplastic Syndromes (MDS)

Comparison of IPSS and IPSS-R Scoring in a Population Based Myelodysplastic Syndromes (MDS) Study

Initial Clinical Findings From a Population-Based Study of Adult Myelodysplastic Syndrome: Discordance Between World Health Organization (WHO) Classifications

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only